Skip to main content
. 2021 Nov 9;11:21923. doi: 10.1038/s41598-021-01452-7

Table 3.

Model performance in early prediction of prognosis in COVID19 patients in the external validation cohort.

Model No significant treatment versus O2 therapy or more No critical care required versus critical care* or death
AUC Cutoff (%) TP/TN/FP/FN Sensitivity Specificity Accuracy Precision NPV AUC Cutoff (%) TP/TN/FP/FN Sensitivity Specificity Accuracy Precision NPV
1 0.829 (0.786–0.869) 30 82/260/46/38 68.3% (59.2–76.5) 85% (80.5–88.8) 80.3% (76.2–84) 64.1% (55.1–72.3) 87.2% (82.9–90.8) 0.827 (0.754–0.901) 11 29/304/84/9 76.3% (59.8–88.6) 78.4% (73.9–82.3) 78.2% (73.9–82) 25.7% (17.9–34.7) 97.1% (94.6–98.7)
2A 0.850 (0.809–0.895) 30 93/245/61/27 77.5% (69–84.6) 80.1% (75.1–84.4) 79.3% (75.2–83.1) 60.4% (52.2–68.2) 90.1% (85.9–93.4) 0.833 (0.759–0.907) 23 24/350/38/14 63.2% (46–78.2) 90.2% (86.8–93) 87.8% (84.3–90.7) 38.7% (26.6–51.9) 96.2% (93.6–97.9)
2B 0.838 (0.796–0.879) 20 93/235/71/27 77.5% (69–84.6) 76.8% (71.7–81.4) 77% (72.7–80.9) 56.7% (48.8–64.4) 89.7% (85.4–93.1) 0.833 (0.759–0.907) 60 24/350/38/14 63.2% (46–78.2) 90.2% (86.8–93) 87.8% (84.3–90.7) 38.7% (26.6–51.9) 96.2% (93.6–97.9)
3 0.861 (0.822–0.902) 29 92/250/56/28 76.7% (68.1–83.9) 81.7% (76.9–85.9) 80.3% (76.2–84) 62.2% (53.8–70.0) 89.9% (85.8–93.2) 0.851 (0.786–0.912) 14 26/333/55/12 68.4% (51.3–82.5) 85.8% (82–89.1) 84.3% (80.5–87.6) 32.1% (22.2–43.4) 96.5% (94–98.2)
4 0.871 (0.834–0.910) 39 95/254/46/25 79.2% (70.8–86.0) 84.7% (80.1–88.6) 83.1% (79.2–86.6) 67.4% (59.0–75.0) 91% (87.1–94.1) 0.864 (0.802–0.916) 12 31/290/92/7 81.6% (65.7–92.3) 75.9% (71.3–80.1) 76.4% (72.1–80.4) 25.2% (17.8–33.8) 97.6% (95.2–99)

Values in parentheses are 95% confidence intervals. AUC area under the receiver operator characteristics curve, TP true positive, TN true negative, FP false positive, FN false negative, NPV negative predictive value.

*The use of a ventilator or extracorporeal membrane oxygenation machine.